Source: centralcharts

Press Release: Biomerica : Biomerica Announces Reverse Stock Split

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) ("Biomerica"), a global provider of advanced medical products, today

Read full article »

Biomerica's Competitors | Biomerica's News | Biomerica's Financials

Followers on Owler

Annual Revenue

$5.0-25M

Employees

25-100

CEO

Zackary Irani

CEO Approval Rating

91/100

Biomerica is a California-based biomedical company that develops and manufactures diagnostic and therapeutic products for gastrointestinal and inflammatory diseases.